Clinical trial

Penfluridol for Relapsed/Refractory Small Cell Cancers

NCT07206563

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2025-10-01

PhasePHASE1 / PHASE2

Study timeline

Study start (estimated)2025-10-01Date precision: day

Registry last updated2025-10-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Small Cell Carcinomaunresolved

Small Cell Carcinoma of Lungunresolved

Small Cell Lung Cancer ( SCLC )unresolved

Small Cell Cervical Carcinomaunresolved

Interventions

Penfluridol Monotherapy for Relapsed/Refractory Small-Cell Lung or Cervical CancerDRUG

Sponsors & collaborators

Union Hospital, Tongji Medical College, Huazhong University of Science and Technologylead sponsor

Mapped research locations

WuhanHubei, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07206563 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.